AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug
Sector
HEALTHCARE
News Type
MARKET
Impact Level
MEDIUM
AI Sentiment
POSITIVE
Published
09 May 2026
📎 Sources
CNBC TV18 | https://www.tradingview.com/news/cnbctv:6b55b0320094b:0/